Skip to main content
Top
Published in: BMC Infectious Diseases 1/2011

Open Access 01-12-2011 | Case report

Chromoblastomycosis after a leech bite complicated by myiasis: a case report

Authors: Günther Slesak, Saythong Inthalad, Michel Strobel, Matthias Marschal, Martin JR Hall, Paul N Newton

Published in: BMC Infectious Diseases | Issue 1/2011

Login to get access

Abstract

Background

Chromoblastomycosis is a chronic mycotic infection, most common in the tropics and subtropics, following traumatic fungal implantation.

Case presentation

A 72 year-old farmer was admitted to Luang Namtha Provincial Hospital, northern Laos, with a growth on the left lower leg which began 1 week after a forefoot leech bite 10 years previously. He presented with a cauliflower-like mass and plaque-like lesions on his lower leg/foot and cellulitis with a purulent tender swelling of his left heel. Twenty-two Chrysomya bezziana larvae were extracted from his heel. PCR of a biopsy of a left lower leg nodule demonstrated Fonsecaea pedrosoi, monophora, or F. nubica. He was successfully treated with long term terbinafin plus itraconazole pulse-therapy and local debridement.

Conclusions

Chromoblastomycosis is reported for the first time from Laos. It carries the danger of bacterial and myiasis superinfection. Leech bites may facilitate infection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ameen M: Chromoblastomycosis: clinical presentation and management. Clin Exp Dermatol. 2009, 34: 849-854. 10.1111/j.1365-2230.2009.03415.x.CrossRefPubMed Ameen M: Chromoblastomycosis: clinical presentation and management. Clin Exp Dermatol. 2009, 34: 849-854. 10.1111/j.1365-2230.2009.03415.x.CrossRefPubMed
2.
go back to reference Bonifaz A, Carrasco-Gerard E, Saúl A: Chromoblastomycosis: clinical and mycologic experience of 51 cases. Mycoses. 2001, 44: 1-7. 10.1046/j.1439-0507.2001.00613.x.CrossRefPubMed Bonifaz A, Carrasco-Gerard E, Saúl A: Chromoblastomycosis: clinical and mycologic experience of 51 cases. Mycoses. 2001, 44: 1-7. 10.1046/j.1439-0507.2001.00613.x.CrossRefPubMed
3.
go back to reference Queiroz-Telles F, Esterre P, Perez-Blanco M, Vitale RG, Salgado CG, Bonifaz A: Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol. 2009, 47: 3-15. 10.1080/13693780802538001.CrossRefPubMed Queiroz-Telles F, Esterre P, Perez-Blanco M, Vitale RG, Salgado CG, Bonifaz A: Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol. 2009, 47: 3-15. 10.1080/13693780802538001.CrossRefPubMed
4.
go back to reference Sauerteig E, Hernández R, Salfelder K, Bastidas C: Acute chromoblastomycosis provoked by an insect bite in an immunosuppressed patient. Mycoses. 1998, 41: 191-194. 10.1111/j.1439-0507.1998.tb00322.x.CrossRefPubMed Sauerteig E, Hernández R, Salfelder K, Bastidas C: Acute chromoblastomycosis provoked by an insect bite in an immunosuppressed patient. Mycoses. 1998, 41: 191-194. 10.1111/j.1439-0507.1998.tb00322.x.CrossRefPubMed
5.
go back to reference Ungpakorn R, Reangchainam S: Pulse itraconazole 400 mg daily in the treatment of chromoblastomycosis. Clin Exp Dermatol. 2006, 31: 245-247. 10.1111/j.1365-2230.2005.02024.x.CrossRefPubMed Ungpakorn R, Reangchainam S: Pulse itraconazole 400 mg daily in the treatment of chromoblastomycosis. Clin Exp Dermatol. 2006, 31: 245-247. 10.1111/j.1365-2230.2005.02024.x.CrossRefPubMed
6.
go back to reference Minotto R, Bernardi CDV, Mallmann LF, Edelweiss MIA, Scroferneker ML: Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul, Brazil. J Am Acad Dermatol. 2001, 44: 585-592. 10.1067/mjd.2001.112220.CrossRefPubMed Minotto R, Bernardi CDV, Mallmann LF, Edelweiss MIA, Scroferneker ML: Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul, Brazil. J Am Acad Dermatol. 2001, 44: 585-592. 10.1067/mjd.2001.112220.CrossRefPubMed
7.
go back to reference Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard. . 2009, Wayne, PA: Clinical and Laboratory Standards Institute, Approved Standard M02-A10., Tenth Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard. . 2009, Wayne, PA: Clinical and Laboratory Standards Institute, Approved Standard M02-A10., Tenth
9.
go back to reference Loeffler J, Hebart H, Bialek R, Hagmeyer L, Schmidt D, Serey FP, Hartmann M, Eucker J, Einsele H: Contaminations occurring in fungal PCR assays. J Clin Microbiol. 1999, 37: 1200-1202.PubMedPubMedCentral Loeffler J, Hebart H, Bialek R, Hagmeyer L, Schmidt D, Serey FP, Hartmann M, Eucker J, Einsele H: Contaminations occurring in fungal PCR assays. J Clin Microbiol. 1999, 37: 1200-1202.PubMedPubMedCentral
10.
go back to reference Leinberger DM, Schumacher U, Autenrieth IB, Bachmann TT: Development of a DNA microarray for detection and identification of fungal pathogens involved in invasive mycoses. J Clin Microbiol. 2005, 43: 4943-53. 10.1128/JCM.43.10.4943-4953.2005.CrossRefPubMedPubMedCentral Leinberger DM, Schumacher U, Autenrieth IB, Bachmann TT: Development of a DNA microarray for detection and identification of fungal pathogens involved in invasive mycoses. J Clin Microbiol. 2005, 43: 4943-53. 10.1128/JCM.43.10.4943-4953.2005.CrossRefPubMedPubMedCentral
11.
go back to reference Einsele H, Hebart H, Roller G, Löffler J, Rothenhöfer I, Müller CA, Bowden RA, Van Burik JA, Engelhard D, Kanz L, Schumacher U: Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol. 1997, 35: 1353-60.PubMedPubMedCentral Einsele H, Hebart H, Roller G, Löffler J, Rothenhöfer I, Müller CA, Bowden RA, Van Burik JA, Engelhard D, Kanz L, Schumacher U: Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol. 1997, 35: 1353-60.PubMedPubMedCentral
12.
go back to reference Zhang J, Xi L, Lu C, Li X, Xie T, Zhang H, Xie Z, Sybren DH: Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China. Mycoses. 2008, 52: 176-181. 10.1111/j.1439-0507.2008.01547.x.CrossRefPubMed Zhang J, Xi L, Lu C, Li X, Xie T, Zhang H, Xie Z, Sybren DH: Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China. Mycoses. 2008, 52: 176-181. 10.1111/j.1439-0507.2008.01547.x.CrossRefPubMed
13.
go back to reference Esterre P, Inzan CK, Ramarcel ER, Andriantsimahavandy A, Ratsioharana M, Pecarrere JL, Roig P: Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study. Br J Dermatol. 1996, 134 (Suppl 46): 33-36. 10.1111/j.1365-2133.1996.tb15658.x.CrossRefPubMed Esterre P, Inzan CK, Ramarcel ER, Andriantsimahavandy A, Ratsioharana M, Pecarrere JL, Roig P: Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study. Br J Dermatol. 1996, 134 (Suppl 46): 33-36. 10.1111/j.1365-2133.1996.tb15658.x.CrossRefPubMed
14.
go back to reference Xi L, Sun J, Lu C, Liu H, Xie Z, Fukushima K, Takizawa K, Najafzadeh MJ, De Hoog GS: Molecular diversity of Fonsecaea (Chaetothyriales) causing chromoblastomycosis in southern China. Med Mycol. 2009, 47: 27-33. 10.1080/13693780802468209.CrossRefPubMed Xi L, Sun J, Lu C, Liu H, Xie Z, Fukushima K, Takizawa K, Najafzadeh MJ, De Hoog GS: Molecular diversity of Fonsecaea (Chaetothyriales) causing chromoblastomycosis in southern China. Med Mycol. 2009, 47: 27-33. 10.1080/13693780802468209.CrossRefPubMed
15.
go back to reference De Andrade TS, Cury AE, de Castro LG, Hirata MH, Hirata RD: Rapid identification of Fonsecaea by duplex polymerase chain reaction in isolates from patients with chromoblastomycosis. Diagn Microbiol Infect Dis. 2007, 57: 267-272. 10.1016/j.diagmicrobio.2006.08.024.CrossRefPubMed De Andrade TS, Cury AE, de Castro LG, Hirata MH, Hirata RD: Rapid identification of Fonsecaea by duplex polymerase chain reaction in isolates from patients with chromoblastomycosis. Diagn Microbiol Infect Dis. 2007, 57: 267-272. 10.1016/j.diagmicrobio.2006.08.024.CrossRefPubMed
16.
go back to reference Sun J, Najafzadeh MJ, Vicente V, Xi L, de Hoog GS: Rapid detection of pathogenic fungi using loop-mediated isothermal amplification, exemplified by Fonsecaea agents of chromoblastomycosis. J Microbiol Methods. 2010, 80: 19-24. 10.1016/j.mimet.2009.10.002.CrossRefPubMed Sun J, Najafzadeh MJ, Vicente V, Xi L, de Hoog GS: Rapid detection of pathogenic fungi using loop-mediated isothermal amplification, exemplified by Fonsecaea agents of chromoblastomycosis. J Microbiol Methods. 2010, 80: 19-24. 10.1016/j.mimet.2009.10.002.CrossRefPubMed
17.
go back to reference Najafzadeh MJ, Sun J, Vicente V, Xi L, van den Ende AH, de Hoog GS: Fonsecaea nubica sp. nov a new agent of human chromoblastomycosis revealed using molecular data. Med Mycol. 2010, 48: 800-6. 10.3109/13693780903503081.CrossRefPubMed Najafzadeh MJ, Sun J, Vicente V, Xi L, van den Ende AH, de Hoog GS: Fonsecaea nubica sp. nov a new agent of human chromoblastomycosis revealed using molecular data. Med Mycol. 2010, 48: 800-6. 10.3109/13693780903503081.CrossRefPubMed
18.
go back to reference White TC, Berny MA, Robinson DK, Yin H, DeGrado WF, Hanson SR, McCarty OJT: The leech product saratin is a potent inhibitor of platelet integrin α2β1 and von Willebrand factor binding to collagen. FEBS J. 2007, 274: 1481-1491. 10.1111/j.1742-4658.2007.05689.x.CrossRefPubMed White TC, Berny MA, Robinson DK, Yin H, DeGrado WF, Hanson SR, McCarty OJT: The leech product saratin is a potent inhibitor of platelet integrin α2β1 and von Willebrand factor binding to collagen. FEBS J. 2007, 274: 1481-1491. 10.1111/j.1742-4658.2007.05689.x.CrossRefPubMed
19.
go back to reference Yeaman MR: Platelets in defense against bacterial pathogens. Cell Mol Life Sci. 2010, 67: 525-544. 10.1007/s00018-009-0210-4.CrossRefPubMed Yeaman MR: Platelets in defense against bacterial pathogens. Cell Mol Life Sci. 2010, 67: 525-544. 10.1007/s00018-009-0210-4.CrossRefPubMed
20.
go back to reference Ardehali B, Hand K, Nduka C, Holmes A, Wood S: Delayed leech-borne infection with Aeromonas hydrophilia in escharotic flap wound. J Plast Reconstr Aesthet Surg. 2006, 59: 94-95. 10.1016/j.bjps.2005.04.030.CrossRefPubMed Ardehali B, Hand K, Nduka C, Holmes A, Wood S: Delayed leech-borne infection with Aeromonas hydrophilia in escharotic flap wound. J Plast Reconstr Aesthet Surg. 2006, 59: 94-95. 10.1016/j.bjps.2005.04.030.CrossRefPubMed
21.
go back to reference Slesak G, Douangdala P, Inthalad S, Silisouk J, Vongsouvath M, Sengduangphachanh A, Moore CE, Mayxay M, Matsuoka H, Newton PN: Fatal Chromobacterium violaceum septicaemia in northern Laos, a modified oxidase test and post-mortem forensic family G6PD analysis. Ann Clin Microbiol Antimicrob. 2009, 8: 24-10.1186/1476-0711-8-24.CrossRefPubMedPubMedCentral Slesak G, Douangdala P, Inthalad S, Silisouk J, Vongsouvath M, Sengduangphachanh A, Moore CE, Mayxay M, Matsuoka H, Newton PN: Fatal Chromobacterium violaceum septicaemia in northern Laos, a modified oxidase test and post-mortem forensic family G6PD analysis. Ann Clin Microbiol Antimicrob. 2009, 8: 24-10.1186/1476-0711-8-24.CrossRefPubMedPubMedCentral
22.
go back to reference Nehili M, Ilk C, Mehlhorn H, Ruhnau K, Dick W, Njayou M: Experiments on the possible role of leeches as vectors of animal and human pathogens: a light and electron microscopy study. Parasitol Res. 1994, 80: 277-290. 10.1007/BF02351867.CrossRefPubMed Nehili M, Ilk C, Mehlhorn H, Ruhnau K, Dick W, Njayou M: Experiments on the possible role of leeches as vectors of animal and human pathogens: a light and electron microscopy study. Parasitol Res. 1994, 80: 277-290. 10.1007/BF02351867.CrossRefPubMed
23.
go back to reference McGraw TA, Turiansky GW: Cutaneous myiasis. J Am Acad Dermatol. 2008, 58: 907-926. 10.1016/j.jaad.2008.03.014.CrossRefPubMed McGraw TA, Turiansky GW: Cutaneous myiasis. J Am Acad Dermatol. 2008, 58: 907-926. 10.1016/j.jaad.2008.03.014.CrossRefPubMed
24.
go back to reference Dooley TA: The edge of tomorrow. . 1958, New York: Farrar, Straus & Cudahy Dooley TA: The edge of tomorrow. . 1958, New York: Farrar, Straus & Cudahy
Metadata
Title
Chromoblastomycosis after a leech bite complicated by myiasis: a case report
Authors
Günther Slesak
Saythong Inthalad
Michel Strobel
Matthias Marschal
Martin JR Hall
Paul N Newton
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2011
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-11-14

Other articles of this Issue 1/2011

BMC Infectious Diseases 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.